Virtual Soapbox Series - Healthcare Video

presented by Alumni Council
Health Edition
Jim Willey '70 
·        Professor of Pulmonary/Critical Care Medicine, College of Medicine and Life Sciences, University of Toledo
·        Medical Director, Eleanor N. Dana Cancer Center
·        George Isaac Chair for Cancer Research Toledo
·        Co-Director for Pulmonary System in M2 Curriculum
·        NIH-funded discovery and development of molecular diagnostic tests and methods focused on assessment of lung cancer risk, diagnosis, and prevention
·        Major advisor for multiple Ph.D. and MD/Ph.D. graduate students
·         Diagnosis and management of pulmonary and critical care disease.
·         Co-Founder: Accugenomics, Inc. Wilmington, NC (

Bobby Mahajan '98, MD
Dr. Mahajan is the medical director of interventional pulmonology and the complex airways disease program at Inova Fairfax Medical Campus. He is board certified in interventional pulmonology, pulmonary medicine, critical care medicine, and internal medicine. He has a special interest in management of malignant complex airway diseases, airway complications following lung transplantation, and bronchoscopic lung volume reduction (BLVR) for patients with severe emphysema. Additionally, he oversees the Inova incidental lung nodule program and the Inova lung cancer screening program. He is fellowship-trained in various procedures including rigid bronchoscopy, stent placement, airway thermal therapy, endobronchial ultrasound bronchoscopy (EBUS), electromagnetic navigation bronchoscopy (EMN), tunneled pleural catheter placement, and endobronchial valve placement.
Dr. Mahajan serves on the board of directors for the American Association of Bronchoscopy and Interventional Pulmonology (AABIP) and is an active member of the Society of Advanced Bronchoscopy (SAB).
Dr. Mahajan is a native of Toledo, OH, and currently resides in Vienna, VA, with his wife and three children. In his spare time he enjoys spending time with his family and playing basketball.
Pratik Multani '84
Current role: Chief Medical Officer at ORIC Pharmaceuticals, San Diego and South San Francisco

Dr. Multani currently serves as Chief Medical Officer at ORIC Pharmaceuticals. Prior to ORIC, Dr. Multani served as Chief Medical Officer of Ignyta, which was acquired by Roche, where he led all development and regulatory activities related to multiple clinical-stage assets, including Ignyta’s lead program entrectinib, which is currently approved in the United States and Japan. He has more than 20 years of experience in oncology drug development and treatment of patients with cancer. 
Prior to his career in biotech, Dr. Multani held academic and clinical positions at Harvard Medical School and at Massachusetts General Hospital. His postdoctoral training included a fellowship in hematology and oncology at Dana-Farber/Partners and an internship and residency in internal medicine at Massachusetts General Hospital. Dr. Multani received an MD from Harvard Medical School and an MS in clinical epidemiology from Harvard School of Public Health. He currently serves on the board of directors of Erasca and Chimerix
Vin Gupta '01, MD, MPA
Chief Health Officer, Amazon; Critical Care Pulmonologist
Dr. Gupta is a critical care pulmonologist, research professor at the University of Washington, and currently serves as Chief Health Officer for Amazon. Additional roles include serving as a Medical Analyst for NBC News and MSNBC and as a Major in the United States Air Force Medical Reserve Corps. His background is in epidemic preparedness, with prior roles at the US Centers for Disease Control, Pentagon's Center for Global Health Engagement, and the Harvard Global Health Institute. You can follow him on Twitter @VinGuptaMD
Melanie Gross  '91
Melanie is Senior Director & Associate  General Counsel at Genentech, Inc. Melanie joined the Genentech Legal  Department in 2008.  Melanie currently leads a team of nine senior attorneys that support Genentech's non-Oncology Business Unit advising in the areas of FDA law and regulations, antitrust, privacy, market access, manufacturing, and some digital health.  Prior to joining  Genentech, Melanie was an Associate in the Washington, D.C. office of the law firm, King & Spalding in the FDA & Life Sciences Practice Group.         
Melanie is passionate about the personal and professional development of others.  Melanie motivates, inspires, challenges, and supports the people she leads and helps them grow, learn, and thrive.  On her own  initiative, Melanie has championed diversity and inclusion, sponsoring programs  to increase awareness of unconscious bias, and helped form and chaired the Legal
Department’s diversity committee, IDEAL (Inclusion & Diversity: Excellence  & Action in Legal).  Melanie has been an active member of the Genentech Women Professionals organization. Her leadership was recognized in 2018 when she received the GWP Emerging Leader  Award.
Katharine Shelley '01, MPH PhD
Health Systems Team Lead, Primary Health Care Program at PATH
Seattle, Washington
Kath is a health systems researcher working to find effective and equitable solutions to the healthcare needs of under-served populations. She focuses on mixed methods approaches to evaluating health systems, with specific interests in primary health care and community health, HIV/AIDS, maternal and child health, economic evaluation, and translating evidence to action. Kath brings 13 years of international public health experience working with academic researchers, non-governmental organizations, and Ministries of Health.

Upcoming Events

List of 1 items.

  • Alumni

    This Months Class Notes
Maumee Valley Country Day School is the only age 3 - 12th grade accredited, co-educational, independent school in Northwest Ohio and Southeast Michigan.